Grifols Growing Again in Clayton with $210M in New Manufacturing Facilities

SourceNorth Carolina Biotechnology Center
Date Published03/23/2018
Author NameBarry Teater
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Grifols
Parent companyGrifols
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):650
Year reshoring announced:2018
Capital investment ($):210
Country(ies) from which reshored:Spain
City reshored to:Clayton
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredplasma medicines
What domestic positive factors made reshoring more attractive?Infrastructure, Proximity to customers/market
Find Reshoring Articles